Ultimovacs ASA Employee Directory

Biotechnology ResearchNorway11-50 Employees

Ultimovacs is a biotech company developing novel immunotherapies against cancer. The lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the nearly universal cancer antigen telomerase, investigated in five randomized Phase 2 trials. 

UV1 is being developed as a therapeutic cancer vaccine for use in combination with other immuno-oncology drugs, which require an ongoing T cell response for their mode of action. Ultimovacs is performing a broad clinical development program with clinical trials in Europe, Australia, and the USA; Five Phase II trials enrolling more than 670 patients at 100 clinics in 15 countries in melanoma, mesothelioma, head & neck cancer, ovarian cancer, and non-small cell lung cancer. 

Ultimovacs was established in 2011. The company and its proprietary technology is based on pre-clinical and clinical research on immunotherapies conducted at the Oslo University Hospital. The company is publicly listed at Euronext Oslo (ULTI). Ultimovacs is headquartered at the Oslo Cancer Cluster Innovation Park in Oslo, Norway, and has an office in Uppsala, Sweden.

Find Ultimovacs ASA employees' phone numbers or email addresses

Ultimovacs ASA Global Highlights

Location
Employees

Europe
7

Minus sign iconPlus sign icon
  • Norway
    7

Asia
1

Minus sign iconPlus sign icon
  • Indonesia
    1

Ultimovacs ASA's Leadership

  • Stylized image of a person
    H. V.
    Chief Financial Officer
    Phone icon
  • Stylized image of a person
    M. W.
    Phone icon

Contact profiles from Ultimovacs ASA

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    H. V.
    Chief Financial Officer
    Phone icon
    Dec 27, 2024
  • Stylized image of a person
    M. W.
    Phone icon
    May 12, 2025

Frequently Asked Questions

What is Ultimovacs ASA known for?

Minus sign iconPlus sign icon
Ultimovacs ASA was founded in 2011 operates in the Biotechnology Research industry. The company's main headquarters is located in Ullernschausseen 64, Oslo, Norge 0379, NO; you can contact the main corporate office by phone at . Explore Ultimovacs ASA's company overview page for more information.

What is Ultimovacs ASA's most common email format?

Minus sign iconPlus sign icon
Ultimovacs ASA employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Ultimovacs ASA email formats with LeadIQ.

How many employees does Ultimovacs ASA have currently?

Minus sign iconPlus sign icon
Ultimovacs ASA has approximately 11 employees as of October 2025. These team members are located across 2 continents, including EuropeAsia.

Who are Ultimovacs ASA's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2025, Ultimovacs ASA's key employees include:

  • Chief Financial Officer: H. V.
  • : M. W.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.